FMRP promotes gastric cancer progression via m6A-dependent stabilization of DVL2 and activation of the Wnt/PCP-JNK pathway
Xiaoyu Hou, Jinlan Gao, Xuesha Xing, Qi Liu, Ming Yi, Chen Liu, Qi Chu, Mengdie Zou, Meirong Hu, Yang Luo · 2026
Read FMRP promotes gastric cancer progression via m6A-dependent stabilization of DVL2 and activation of the Wnt/PCP-JNK pathway by Xiaoyu Hou, Jinlan Gao, Xuesha Xing, Qi Liu, Ming Yi, Chen Liu, Qi Chu, Mengdie Zou, Meirong Hu, Yang Luo (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13545764.txt.
Description
Xiaoyu Hou and co-authors name a driver of stomach cancer growth in a 2026 study. The driver is a protein that grips RNA, and a cell mark that sits on RNA and steers fate has risen as a key theme in this cancer.
Reads of tumor banks and of sliced tissue showed the protein far up in the cancer. When the team drained it, tumors grew and spread less, in dishes and in mice. Its mark is a partner gene whose strand the protein latches onto and keeps sound, by grace of that RNA mark. One spot on the strand bore the rule. Through that partner the protein fires a growth path and makes cells breed, creep, and invade more. The authors cast the pair as a drug mark.
Catalog record
| CREATOR | Xiaoyu Hou, Jinlan Gao, Xuesha Xing, Qi Liu, Ming Yi, Chen Liu, Qi Chu, Mengdie Zou, Meirong Hu, Yang Luo |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 66 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |